HYTN Innovations Inc ( (TSE:HYTN) ) has provided an announcement.
HYTN Innovations Inc. has received Good Manufacturing Practices (GMP) certificates from Health Canada for its manufacturing facility in Kelowna, confirming compliance for the United States, Bermuda, and Israel. These certifications enhance HYTN’s ability to support drug registrations, facilitate clinical trials, and offer contract manufacturing for cannabis and psilocybin-based pharmaceuticals, positioning the company for international growth and strengthening its leadership in high-quality manufacturing practices.
More about HYTN Innovations Inc
HYTN Innovations Inc. is a pharmaceutical company that specializes in the formulation, manufacturing, marketing, and sale of products containing psychoactive and psychotropic compounds, such as cannabis-derived cannabinoids and psilocybe-derived tryptamines. The company aims to be a leading provider in federally regulated markets by strategically identifying opportunities and introducing innovative products through its advanced development platform.
YTD Price Performance: -22.22%
Average Trading Volume: 73,683
Technical Sentiment Signal: Strong Buy
Current Market Cap: C$21.82M
Learn more about HYTN stock on TipRanks’ Stock Analysis page.